Literature DB >> 18542080

The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.

Jorge R Oksenberg1, Sergio E Baranzini, Stephen Sawcer, Stephen L Hauser.   

Abstract

Multiple sclerosis (MS) is an autoimmune demyelinating disease and a common cause of neurological disability in young adults. The modest heritability of MS reflects complex genetic effects and multifaceted gene-environment interactions. The human leukocyte antigen (HLA) region is the strongest susceptibility locus for MS, but a genome-wide association study recently identified new susceptibility genes. Progress in high-throughput genotyping and sequencing technologies and a better understanding of the structural organization of the human genome, together with powerful brain-imaging techniques that refine the phenotype, suggest that the tools could finally exist to identify the full set of genes influencing the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18542080     DOI: 10.1038/nrg2395

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  100 in total

Review 1.  The epigenetics of autoimmunity.

Authors:  Francesca Meda; Marco Folci; Andrea Baccarelli; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

3.  Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis.

Authors:  Alessandra Ferlini; Matteo Bovolenta; Marcella Neri; Francesca Gualandi; Alessandra Balboni; Anton Yuryev; Fabrizio Salvi; Donato Gemmati; Alberto Liboni; Paolo Zamboni
Journal:  BMC Med Genet       Date:  2010-04-28       Impact factor: 2.103

Review 4.  Genome-wide approaches to schizophrenia.

Authors:  Jubao Duan; Alan R Sanders; Pablo V Gejman
Journal:  Brain Res Bull       Date:  2010-04-28       Impact factor: 4.077

Review 5.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

Review 6.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.

Authors:  Robert H Miller; Sharyl L Fyffe-Maricich
Journal:  Dis Model Mech       Date:  2010-07-20       Impact factor: 5.758

7.  ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment.

Authors:  Anna Malishkevich; Janina Leyk; Olaf Goldbaum; Christiane Richter-Landsberg; Illana Gozes
Journal:  J Mol Neurosci       Date:  2015-10       Impact factor: 3.444

Review 8.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.

Authors:  Leslie E Summers deLuca; Natalia B Pikor; Jennifer O'Leary; Georgina Galicia-Rosas; Lesley A Ward; Dustin Defreitas; Trisha M Finlay; Shalina S Ousman; Lucy R Osborne; Jennifer L Gommerman
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

10.  Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.

Authors:  Dorothea Buck; Eva Albrecht; Muhammad Aslam; An Goris; Natalie Hauenstein; Angela Jochim; Sabine Cepok; Verena Grummel; Bénédicte Dubois; Achim Berthele; Peter Lichtner; Christian Gieger; Juliane Winkelmann; Bernhard Hemmer
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.